SCHEMBL29636634

SCHEMBL29636634

NCCC(N)c1cc(-c2cnn(C3CCNCC3)c2)nc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 4/20 0.48
KCNH2 Q12809 2/20 0.48
CHRNB2 P17787 1/20 0.47
CHRNA4 P43681 1/20 0.47
ALK Q9UM73 3/20 0.46
MAP4K3 Q8IVH8 5/20 0.45
NTRK1 P04629 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP3A5 P20815 2/20 0.43
CYP3A7 P24462 2/20 0.43
CYP2C19 P33261 2/20 0.43
PDK4 Q16654 2/20 0.43
CYP3A43 Q9HB55 2/20 0.43
MAP3K7 O43318 1/20 0.43
TAB1 Q15750 1/20 0.43
KHK P50053 1/20 0.43
GRK5 P34947 2/20 0.43
GRK2 P25098 1/20 0.42
FLT3 P36888 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23015213 1.00 MET (0.48) METKCNH2CHRNB2CHRNA4ALK
SCHEMBL23015372 0.88 EGFR (0.49) METNTRK1KHKFLT3JAK2
SCHEMBL29636681 0.88 EGFR (0.49) METNTRK1KHKFLT3JAK2
SCHEMBL29636726 0.80 GRM2 (0.46) MET
SCHEMBL23015344 0.80 GRM2 (0.46) MET
SCHEMBL23029690 0.79 ACP1 (0.50) ALKMAP4K3NTRK1
SCHEMBL29636642 0.79 DHODH (0.45) CYP1A2CYP2C19
SCHEMBL23015138 0.79 DHODH (0.45) CYP1A2CYP2C19
SCHEMBL29636644 0.76 KMT2A (0.42) CYP1A2CYP3A4CYP2C19
SCHEMBL28967174 0.76 KMT2A (0.42) CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017492-A1 MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS Biohaven Therapeutics Ltd. (US) 2022-06-29 EP claimed